| Section | 3 | Administration |
| Body System | E | Physiological Systems and Anatomical Regions |
| Operation | 0 | Introduction: Putting in or on a therapeutic, diagnostic, nutritional, physiological, or prophylactic substance except blood or blood products |
| Body System / Region 0 Skin and Mucous Membranes |
Approach X External |
Substance 0 Antineoplastic |
Qualifier 5 Other Antineoplastic M Monoclonal Antibody |
| Body System / Region 0 Skin and Mucous Membranes |
Approach X External |
Substance 2 Anti-infective |
Qualifier 8 Oxazolidinones 9 Other Anti-infective |
| Body System / Region 0 Skin and Mucous Membranes |
Approach X External |
Substance 3 Anti-inflammatory 4 Serum, Toxoid and Vaccine B Local Anesthetic K Other Diagnostic Substance M Pigment N Analgesics, Hypnotics, Sedatives T Destructive Agent |
Qualifier Z No Qualifier |
| Body System / Region 0 Skin and Mucous Membranes |
Approach X External |
Substance G Other Therapeutic Substance |
Qualifier C Other Substance |
| Body System / Region 1 Subcutaneous Tissue |
Approach 0 Open |
Substance 2 Anti-infective |
Qualifier A Anti-Infective Envelope |
| Body System / Region 1 Subcutaneous Tissue |
Approach 3 Percutaneous |
Substance 0 Antineoplastic |
Qualifier 5 Other Antineoplastic M Monoclonal Antibody |
| Body System / Region 1 Subcutaneous Tissue |
Approach 3 Percutaneous |
Substance 2 Anti-infective |
Qualifier 8 Oxazolidinones 9 Other Anti-infective A Anti-Infective Envelope |
| Body System / Region 1 Subcutaneous Tissue |
Approach 3 Percutaneous |
Substance 3 Anti-inflammatory 4 Serum, Toxoid and Vaccine 6 Nutritional Substance 7 Electrolytic and Water Balance Substance B Local Anesthetic H Radioactive Substance K Other Diagnostic Substance N Analgesics, Hypnotics, Sedatives T Destructive Agent |
Qualifier Z No Qualifier |
| Body System / Region 1 Subcutaneous Tissue |
Approach 3 Percutaneous |
Substance G Other Therapeutic Substance |
Qualifier C Other Substance |
| Body System / Region 1 Subcutaneous Tissue |
Approach 3 Percutaneous |
Substance V Hormone |
Qualifier G Insulin J Other Hormone |
| Body System / Region 2 Muscle |
Approach 3 Percutaneous |
Substance 0 Antineoplastic |
Qualifier 5 Other Antineoplastic M Monoclonal Antibody |
| Body System / Region 2 Muscle |
Approach 3 Percutaneous |
Substance 2 Anti-infective |
Qualifier 8 Oxazolidinones 9 Other Anti-infective |
| Body System / Region 2 Muscle |
Approach 3 Percutaneous |
Substance 3 Anti-inflammatory 4 Serum, Toxoid and Vaccine 6 Nutritional Substance 7 Electrolytic and Water Balance Substance B Local Anesthetic H Radioactive Substance K Other Diagnostic Substance N Analgesics, Hypnotics, Sedatives T Destructive Agent |
Qualifier Z No Qualifier |
| Body System / Region 2 Muscle |
Approach 3 Percutaneous |
Substance G Other Therapeutic Substance |
Qualifier C Other Substance |
| Body System / Region 3 Peripheral Vein |
Approach 0 Open |
Substance 0 Antineoplastic |
Qualifier 2 High-dose Interleukin-2 3 Low-dose Interleukin-2 5 Other Antineoplastic M Monoclonal Antibody P Clofarabine |
| Body System / Region 3 Peripheral Vein |
Approach 0 Open |
Substance 1 Thrombolytic |
Qualifier 6 Recombinant Human-activated Protein C 7 Other Thrombolytic |
| Body System / Region 3 Peripheral Vein |
Approach 0 Open |
Substance 2 Anti-infective |
Qualifier 8 Oxazolidinones 9 Other Anti-infective |
| Body System / Region 3 Peripheral Vein |
Approach 0 Open |
Substance 3 Anti-inflammatory 4 Serum, Toxoid and Vaccine 6 Nutritional Substance 7 Electrolytic and Water Balance Substance F Intracirculatory Anesthetic H Radioactive Substance K Other Diagnostic Substance N Analgesics, Hypnotics, Sedatives P Platelet Inhibitor R Antiarrhythmic T Destructive Agent X Vasopressor |
Qualifier Z No Qualifier |
| Body System / Region 3 Peripheral Vein |
Approach 0 Open |
Substance G Other Therapeutic Substance |
Qualifier C Other Substance N Blood Brain Barrier Disruption |
| Body System / Region 3 Peripheral Vein |
Approach 0 Open |
Substance U Pancreatic Islet Cells |
Qualifier 0 Autologous 1 Nonautologous |
| Body System / Region 3 Peripheral Vein |
Approach 0 Open |
Substance V Hormone |
Qualifier G Insulin H Human B-type Natriuretic Peptide J Other Hormone |
| Body System / Region 3 Peripheral Vein |
Approach 0 Open |
Substance W Immunotherapeutic |
Qualifier K Immunostimulator L Immunosuppressive |
| Body System / Region 3 Peripheral Vein |
Approach 3 Percutaneous |
Substance 0 Antineoplastic |
Qualifier 2 High-dose Interleukin-2 3 Low-dose Interleukin-2 5 Other Antineoplastic M Monoclonal Antibody P Clofarabine |
| Body System / Region 3 Peripheral Vein |
Approach 3 Percutaneous |
Substance 1 Thrombolytic |
Qualifier 6 Recombinant Human-activated Protein C 7 Other Thrombolytic |
| Body System / Region 3 Peripheral Vein |
Approach 3 Percutaneous |
Substance 2 Anti-infective |
Qualifier 8 Oxazolidinones 9 Other Anti-infective |
| Body System / Region 3 Peripheral Vein |
Approach 3 Percutaneous |
Substance 3 Anti-inflammatory 4 Serum, Toxoid and Vaccine 6 Nutritional Substance 7 Electrolytic and Water Balance Substance F Intracirculatory Anesthetic H Radioactive Substance K Other Diagnostic Substance N Analgesics, Hypnotics, Sedatives P Platelet Inhibitor R Antiarrhythmic T Destructive Agent X Vasopressor |
Qualifier Z No Qualifier |
| Body System / Region 3 Peripheral Vein |
Approach 3 Percutaneous |
Substance G Other Therapeutic Substance |
Qualifier C Other Substance N Blood Brain Barrier Disruption Q Glucarpidase |
| Body System / Region 3 Peripheral Vein |
Approach 3 Percutaneous |
Substance U Pancreatic Islet Cells |
Qualifier 0 Autologous 1 Nonautologous |
| Body System / Region 3 Peripheral Vein |
Approach 3 Percutaneous |
Substance V Hormone |
Qualifier G Insulin H Human B-type Natriuretic Peptide J Other Hormone |
| Body System / Region 3 Peripheral Vein |
Approach 3 Percutaneous |
Substance W Immunotherapeutic |
Qualifier K Immunostimulator L Immunosuppressive |
| Body System / Region 4 Central Vein |
Approach 0 Open |
Substance 0 Antineoplastic |
Qualifier 2 High-dose Interleukin-2 3 Low-dose Interleukin-2 5 Other Antineoplastic M Monoclonal Antibody P Clofarabine |
| Body System / Region 4 Central Vein |
Approach 0 Open |
Substance 1 Thrombolytic |
Qualifier 6 Recombinant Human-activated Protein C 7 Other Thrombolytic |
| Body System / Region 4 Central Vein |
Approach 0 Open |
Substance 2 Anti-infective |
Qualifier 8 Oxazolidinones 9 Other Anti-infective |
| Body System / Region 4 Central Vein |
Approach 0 Open |
Substance 3 Anti-inflammatory 4 Serum, Toxoid and Vaccine 6 Nutritional Substance 7 Electrolytic and Water Balance Substance F Intracirculatory Anesthetic H Radioactive Substance K Other Diagnostic Substance N Analgesics, Hypnotics, Sedatives P Platelet Inhibitor R Antiarrhythmic T Destructive Agent X Vasopressor |
Qualifier Z No Qualifier |
| Body System / Region 4 Central Vein |
Approach 0 Open |
Substance G Other Therapeutic Substance |
Qualifier C Other Substance N Blood Brain Barrier Disruption |
| Body System / Region 4 Central Vein |
Approach 0 Open |
Substance V Hormone |
Qualifier G Insulin H Human B-type Natriuretic Peptide J Other Hormone |
| Body System / Region 4 Central Vein |
Approach 0 Open |
Substance W Immunotherapeutic |
Qualifier K Immunostimulator L Immunosuppressive |
| Body System / Region 4 Central Vein |
Approach 3 Percutaneous |
Substance 0 Antineoplastic |
Qualifier 2 High-dose Interleukin-2 3 Low-dose Interleukin-2 5 Other Antineoplastic M Monoclonal Antibody P Clofarabine |
| Body System / Region 4 Central Vein |
Approach 3 Percutaneous |
Substance 1 Thrombolytic |
Qualifier 6 Recombinant Human-activated Protein C 7 Other Thrombolytic |
| Body System / Region 4 Central Vein |
Approach 3 Percutaneous |
Substance 2 Anti-infective |
Qualifier 8 Oxazolidinones 9 Other Anti-infective |
| Body System / Region 4 Central Vein |
Approach 3 Percutaneous |
Substance 3 Anti-inflammatory 4 Serum, Toxoid and Vaccine 6 Nutritional Substance 7 Electrolytic and Water Balance Substance F Intracirculatory Anesthetic H Radioactive Substance K Other Diagnostic Substance N Analgesics, Hypnotics, Sedatives P Platelet Inhibitor R Antiarrhythmic T Destructive Agent X Vasopressor |
Qualifier Z No Qualifier |
| Body System / Region 4 Central Vein |
Approach 3 Percutaneous |
Substance G Other Therapeutic Substance |
Qualifier C Other Substance N Blood Brain Barrier Disruption Q Glucarpidase |
| Body System / Region 4 Central Vein |
Approach 3 Percutaneous |
Substance V Hormone |
Qualifier G Insulin H Human B-type Natriuretic Peptide J Other Hormone |
| Body System / Region 4 Central Vein |
Approach 3 Percutaneous |
Substance W Immunotherapeutic |
Qualifier K Immunostimulator L Immunosuppressive |
| Body System / Region 5 Peripheral Artery 6 Central Artery |
Approach 0 Open 3 Percutaneous |
Substance 0 Antineoplastic |
Qualifier 2 High-dose Interleukin-2 3 Low-dose Interleukin-2 5 Other Antineoplastic M Monoclonal Antibody P Clofarabine |
| Body System / Region 5 Peripheral Artery 6 Central Artery |
Approach 0 Open 3 Percutaneous |
Substance 1 Thrombolytic |
Qualifier 6 Recombinant Human-activated Protein C 7 Other Thrombolytic |
| Body System / Region 5 Peripheral Artery 6 Central Artery |
Approach 0 Open 3 Percutaneous |
Substance 2 Anti-infective |
Qualifier 8 Oxazolidinones 9 Other Anti-infective |
| Body System / Region 5 Peripheral Artery 6 Central Artery |
Approach 0 Open 3 Percutaneous |
Substance 3 Anti-inflammatory 4 Serum, Toxoid and Vaccine 6 Nutritional Substance 7 Electrolytic and Water Balance Substance F Intracirculatory Anesthetic H Radioactive Substance K Other Diagnostic Substance N Analgesics, Hypnotics, Sedatives P Platelet Inhibitor R Antiarrhythmic T Destructive Agent X Vasopressor |
Qualifier Z No Qualifier |
| Body System / Region 5 Peripheral Artery 6 Central Artery |
Approach 0 Open 3 Percutaneous |
Substance G Other Therapeutic Substance |
Qualifier C Other Substance N Blood Brain Barrier Disruption |
| Body System / Region 5 Peripheral Artery 6 Central Artery |
Approach 0 Open 3 Percutaneous |
Substance V Hormone |
Qualifier G Insulin H Human B-type Natriuretic Peptide J Other Hormone |
| Body System / Region 5 Peripheral Artery 6 Central Artery |
Approach 0 Open 3 Percutaneous |
Substance W Immunotherapeutic |
Qualifier K Immunostimulator L Immunosuppressive |
| Body System / Region 7 Coronary Artery 8 Heart |
Approach 0 Open 3 Percutaneous |
Substance 1 Thrombolytic |
Qualifier 6 Recombinant Human-activated Protein C 7 Other Thrombolytic |
| Body System / Region 7 Coronary Artery 8 Heart |
Approach 0 Open 3 Percutaneous |
Substance G Other Therapeutic Substance |
Qualifier C Other Substance |
| Body System / Region 7 Coronary Artery 8 Heart |
Approach 0 Open 3 Percutaneous |
Substance K Other Diagnostic Substance P Platelet Inhibitor |
Qualifier Z No Qualifier |
| Body System / Region 9 Nose |
Approach 3 Percutaneous 7 Via Natural or Artificial Opening X External |
Substance 0 Antineoplastic |
Qualifier 5 Other Antineoplastic M Monoclonal Antibody |
| Body System / Region 9 Nose |
Approach 3 Percutaneous 7 Via Natural or Artificial Opening X External |
Substance 2 Anti-infective |
Qualifier 8 Oxazolidinones 9 Other Anti-infective |
| Body System / Region 9 Nose |
Approach 3 Percutaneous 7 Via Natural or Artificial Opening X External |
Substance 3 Anti-inflammatory 4 Serum, Toxoid and Vaccine B Local Anesthetic H Radioactive Substance K Other Diagnostic Substance N Analgesics, Hypnotics, Sedatives T Destructive Agent |
Qualifier Z No Qualifier |
| Body System / Region 9 Nose |
Approach 3 Percutaneous 7 Via Natural or Artificial Opening X External |
Substance G Other Therapeutic Substance |
Qualifier C Other Substance |
| Body System / Region A Bone Marrow |
Approach 3 Percutaneous |
Substance 0 Antineoplastic |
Qualifier 5 Other Antineoplastic M Monoclonal Antibody |
| Body System / Region A Bone Marrow |
Approach 3 Percutaneous |
Substance G Other Therapeutic Substance |
Qualifier C Other Substance |
| Body System / Region B Ear |
Approach 3 Percutaneous 7 Via Natural or Artificial Opening X External |
Substance 0 Antineoplastic |
Qualifier 4 Liquid Brachytherapy Radioisotope 5 Other Antineoplastic M Monoclonal Antibody |
| Body System / Region B Ear |
Approach 3 Percutaneous 7 Via Natural or Artificial Opening X External |
Substance 2 Anti-infective |
Qualifier 8 Oxazolidinones 9 Other Anti-infective |
| Body System / Region B Ear |
Approach 3 Percutaneous 7 Via Natural or Artificial Opening X External |
Substance 3 Anti-inflammatory B Local Anesthetic H Radioactive Substance K Other Diagnostic Substance N Analgesics, Hypnotics, Sedatives T Destructive Agent |
Qualifier Z No Qualifier |
| Body System / Region B Ear |
Approach 3 Percutaneous 7 Via Natural or Artificial Opening X External |
Substance G Other Therapeutic Substance |
Qualifier C Other Substance |
| Body System / Region C Eye |
Approach 3 Percutaneous 7 Via Natural or Artificial Opening X External |
Substance 0 Antineoplastic |
Qualifier 4 Liquid Brachytherapy Radioisotope 5 Other Antineoplastic M Monoclonal Antibody |
| Body System / Region C Eye |
Approach 3 Percutaneous 7 Via Natural or Artificial Opening X External |
Substance 2 Anti-infective |
Qualifier 8 Oxazolidinones 9 Other Anti-infective |
| Body System / Region C Eye |
Approach 3 Percutaneous 7 Via Natural or Artificial Opening X External |
Substance 3 Anti-inflammatory B Local Anesthetic H Radioactive Substance K Other Diagnostic Substance M Pigment N Analgesics, Hypnotics, Sedatives T Destructive Agent |
Qualifier Z No Qualifier |
| Body System / Region C Eye |
Approach 3 Percutaneous 7 Via Natural or Artificial Opening X External |
Substance G Other Therapeutic Substance |
Qualifier C Other Substance |
| Body System / Region C Eye |
Approach 3 Percutaneous 7 Via Natural or Artificial Opening X External |
Substance S Gas |
Qualifier F Other Gas |
| Body System / Region D Mouth and Pharynx |
Approach 3 Percutaneous 7 Via Natural or Artificial Opening X External |
Substance 0 Antineoplastic |
Qualifier 4 Liquid Brachytherapy Radioisotope 5 Other Antineoplastic M Monoclonal Antibody |
| Body System / Region D Mouth and Pharynx |
Approach 3 Percutaneous 7 Via Natural or Artificial Opening X External |
Substance 2 Anti-infective |
Qualifier 8 Oxazolidinones 9 Other Anti-infective |
| Body System / Region D Mouth and Pharynx |
Approach 3 Percutaneous 7 Via Natural or Artificial Opening X External |
Substance 3 Anti-inflammatory 4 Serum, Toxoid and Vaccine 6 Nutritional Substance 7 Electrolytic and Water Balance Substance B Local Anesthetic H Radioactive Substance K Other Diagnostic Substance N Analgesics, Hypnotics, Sedatives R Antiarrhythmic T Destructive Agent |
Qualifier Z No Qualifier |
| Body System / Region D Mouth and Pharynx |
Approach 3 Percutaneous 7 Via Natural or Artificial Opening X External |
Substance G Other Therapeutic Substance |
Qualifier C Other Substance |
| Body System / Region E Products of Conception G Upper GI H Lower GI K Genitourinary Tract N Male Reproductive |
Approach 3 Percutaneous 7 Via Natural or Artificial Opening 8 Via Natural or Artificial Opening Endoscopic |
Substance 0 Antineoplastic |
Qualifier 4 Liquid Brachytherapy Radioisotope 5 Other Antineoplastic M Monoclonal Antibody |
| Body System / Region E Products of Conception G Upper GI H Lower GI K Genitourinary Tract N Male Reproductive |
Approach 3 Percutaneous 7 Via Natural or Artificial Opening 8 Via Natural or Artificial Opening Endoscopic |
Substance 2 Anti-infective |
Qualifier 8 Oxazolidinones 9 Other Anti-infective |
| Body System / Region E Products of Conception G Upper GI H Lower GI K Genitourinary Tract N Male Reproductive |
Approach 3 Percutaneous 7 Via Natural or Artificial Opening 8 Via Natural or Artificial Opening Endoscopic |
Substance 3 Anti-inflammatory 6 Nutritional Substance 7 Electrolytic and Water Balance Substance B Local Anesthetic H Radioactive Substance K Other Diagnostic Substance N Analgesics, Hypnotics, Sedatives T Destructive Agent |
Qualifier Z No Qualifier |
| Body System / Region E Products of Conception G Upper GI H Lower GI K Genitourinary Tract N Male Reproductive |
Approach 3 Percutaneous 7 Via Natural or Artificial Opening 8 Via Natural or Artificial Opening Endoscopic |
Substance G Other Therapeutic Substance |
Qualifier C Other Substance |
| Body System / Region E Products of Conception G Upper GI H Lower GI K Genitourinary Tract N Male Reproductive |
Approach 3 Percutaneous 7 Via Natural or Artificial Opening 8 Via Natural or Artificial Opening Endoscopic |
Substance S Gas |
Qualifier F Other Gas |
| Body System / Region F Respiratory Tract |
Approach 3 Percutaneous |
Substance 0 Antineoplastic |
Qualifier 4 Liquid Brachytherapy Radioisotope 5 Other Antineoplastic M Monoclonal Antibody |
| Body System / Region F Respiratory Tract |
Approach 3 Percutaneous |
Substance 2 Anti-infective |
Qualifier 8 Oxazolidinones 9 Other Anti-infective |
| Body System / Region F Respiratory Tract |
Approach 3 Percutaneous |
Substance 3 Anti-inflammatory 6 Nutritional Substance 7 Electrolytic and Water Balance Substance B Local Anesthetic H Radioactive Substance K Other Diagnostic Substance N Analgesics, Hypnotics, Sedatives T Destructive Agent |
Qualifier Z No Qualifier |
| Body System / Region F Respiratory Tract |
Approach 3 Percutaneous |
Substance G Other Therapeutic Substance |
Qualifier C Other Substance |
| Body System / Region F Respiratory Tract |
Approach 3 Percutaneous |
Substance S Gas |
Qualifier D Nitric Oxide F Other Gas |
| Body System / Region F Respiratory Tract |
Approach 7 Via Natural or Artificial Opening 8 Via Natural or Artificial Opening Endoscopic |
Substance 0 Antineoplastic |
Qualifier 4 Liquid Brachytherapy Radioisotope 5 Other Antineoplastic M Monoclonal Antibody |
| Body System / Region F Respiratory Tract |
Approach 7 Via Natural or Artificial Opening 8 Via Natural or Artificial Opening Endoscopic |
Substance 2 Anti-infective |
Qualifier 8 Oxazolidinones 9 Other Anti-infective |
| Body System / Region F Respiratory Tract |
Approach 7 Via Natural or Artificial Opening 8 Via Natural or Artificial Opening Endoscopic |
Substance 3 Anti-inflammatory 6 Nutritional Substance 7 Electrolytic and Water Balance Substance B Local Anesthetic D Inhalation Anesthetic H Radioactive Substance K Other Diagnostic Substance N Analgesics, Hypnotics, Sedatives T Destructive Agent |
Qualifier Z No Qualifier |
| Body System / Region F Respiratory Tract |
Approach 7 Via Natural or Artificial Opening 8 Via Natural or Artificial Opening Endoscopic |
Substance G Other Therapeutic Substance |
Qualifier C Other Substance |
| Body System / Region F Respiratory Tract |
Approach 7 Via Natural or Artificial Opening 8 Via Natural or Artificial Opening Endoscopic |
Substance S Gas |
Qualifier D Nitric Oxide F Other Gas |
| Body System / Region J Biliary and Pancreatic Tract |
Approach 3 Percutaneous 7 Via Natural or Artificial Opening 8 Via Natural or Artificial Opening Endoscopic |
Substance 0 Antineoplastic |
Qualifier 4 Liquid Brachytherapy Radioisotope 5 Other Antineoplastic M Monoclonal Antibody |
| Body System / Region J Biliary and Pancreatic Tract |
Approach 3 Percutaneous 7 Via Natural or Artificial Opening 8 Via Natural or Artificial Opening Endoscopic |
Substance 2 Anti-infective |
Qualifier 8 Oxazolidinones 9 Other Anti-infective |
| Body System / Region J Biliary and Pancreatic Tract |
Approach 3 Percutaneous 7 Via Natural or Artificial Opening 8 Via Natural or Artificial Opening Endoscopic |
Substance 3 Anti-inflammatory 6 Nutritional Substance 7 Electrolytic and Water Balance Substance B Local Anesthetic H Radioactive Substance K Other Diagnostic Substance N Analgesics, Hypnotics, Sedatives T Destructive Agent |
Qualifier Z No Qualifier |
| Body System / Region J Biliary and Pancreatic Tract |
Approach 3 Percutaneous 7 Via Natural or Artificial Opening 8 Via Natural or Artificial Opening Endoscopic |
Substance G Other Therapeutic Substance |
Qualifier C Other Substance |
| Body System / Region J Biliary and Pancreatic Tract |
Approach 3 Percutaneous 7 Via Natural or Artificial Opening 8 Via Natural or Artificial Opening Endoscopic |
Substance S Gas |
Qualifier F Other Gas |
| Body System / Region J Biliary and Pancreatic Tract |
Approach 3 Percutaneous 7 Via Natural or Artificial Opening 8 Via Natural or Artificial Opening Endoscopic |
Substance U Pancreatic Islet Cells |
Qualifier 0 Autologous 1 Nonautologous |
| Body System / Region L Pleural Cavity M Peritoneal Cavity |
Approach 0 Open |
Substance 5 Adhesion Barrier |
Qualifier Z No Qualifier |
| Body System / Region L Pleural Cavity M Peritoneal Cavity |
Approach 3 Percutaneous |
Substance 0 Antineoplastic |
Qualifier 4 Liquid Brachytherapy Radioisotope 5 Other Antineoplastic M Monoclonal Antibody |
| Body System / Region L Pleural Cavity M Peritoneal Cavity |
Approach 3 Percutaneous |
Substance 2 Anti-infective |
Qualifier 8 Oxazolidinones 9 Other Anti-infective |
| Body System / Region L Pleural Cavity M Peritoneal Cavity |
Approach 3 Percutaneous |
Substance 3 Anti-inflammatory 6 Nutritional Substance 7 Electrolytic and Water Balance Substance B Local Anesthetic H Radioactive Substance K Other Diagnostic Substance N Analgesics, Hypnotics, Sedatives T Destructive Agent |
Qualifier Z No Qualifier |
| Body System / Region L Pleural Cavity M Peritoneal Cavity |
Approach 3 Percutaneous |
Substance G Other Therapeutic Substance |
Qualifier C Other Substance |
| Body System / Region L Pleural Cavity M Peritoneal Cavity |
Approach 3 Percutaneous |
Substance S Gas |
Qualifier F Other Gas |
| Body System / Region L Pleural Cavity M Peritoneal Cavity |
Approach 7 Via Natural or Artificial Opening |
Substance 0 Antineoplastic |
Qualifier 4 Liquid Brachytherapy Radioisotope 5 Other Antineoplastic M Monoclonal Antibody |
| Body System / Region L Pleural Cavity M Peritoneal Cavity |
Approach 7 Via Natural or Artificial Opening |
Substance S Gas |
Qualifier F Other Gas |
| Body System / Region P Female Reproductive |
Approach 0 Open |
Substance 5 Adhesion Barrier |
Qualifier Z No Qualifier |
| Body System / Region P Female Reproductive |
Approach 3 Percutaneous 7 Via Natural or Artificial Opening |
Substance 0 Antineoplastic |
Qualifier 4 Liquid Brachytherapy Radioisotope 5 Other Antineoplastic M Monoclonal Antibody |
| Body System / Region P Female Reproductive |
Approach 3 Percutaneous 7 Via Natural or Artificial Opening |
Substance 2 Anti-infective |
Qualifier 8 Oxazolidinones 9 Other Anti-infective |
| Body System / Region P Female Reproductive |
Approach 3 Percutaneous 7 Via Natural or Artificial Opening |
Substance 3 Anti-inflammatory 6 Nutritional Substance 7 Electrolytic and Water Balance Substance B Local Anesthetic H Radioactive Substance K Other Diagnostic Substance L Sperm N Analgesics, Hypnotics, Sedatives T Destructive Agent |
Qualifier Z No Qualifier |
| Body System / Region P Female Reproductive |
Approach 3 Percutaneous 7 Via Natural or Artificial Opening |
Substance G Other Therapeutic Substance |
Qualifier C Other Substance |
| Body System / Region P Female Reproductive |
Approach 3 Percutaneous 7 Via Natural or Artificial Opening |
Substance Q Fertilized Ovum |
Qualifier 0 Autologous 1 Nonautologous |
| Body System / Region P Female Reproductive |
Approach 3 Percutaneous 7 Via Natural or Artificial Opening |
Substance S Gas |
Qualifier F Other Gas |
| Body System / Region P Female Reproductive |
Approach 8 Via Natural or Artificial Opening Endoscopic |
Substance 0 Antineoplastic |
Qualifier 4 Liquid Brachytherapy Radioisotope 5 Other Antineoplastic M Monoclonal Antibody |
| Body System / Region P Female Reproductive |
Approach 8 Via Natural or Artificial Opening Endoscopic |
Substance 2 Anti-infective |
Qualifier 8 Oxazolidinones 9 Other Anti-infective |
| Body System / Region P Female Reproductive |
Approach 8 Via Natural or Artificial Opening Endoscopic |
Substance 3 Anti-inflammatory 6 Nutritional Substance 7 Electrolytic and Water Balance Substance B Local Anesthetic H Radioactive Substance K Other Diagnostic Substance N Analgesics, Hypnotics, Sedatives T Destructive Agent |
Qualifier Z No Qualifier |
| Body System / Region P Female Reproductive |
Approach 8 Via Natural or Artificial Opening Endoscopic |
Substance G Other Therapeutic Substance |
Qualifier C Other Substance |
| Body System / Region P Female Reproductive |
Approach 8 Via Natural or Artificial Opening Endoscopic |
Substance S Gas |
Qualifier F Other Gas |
| Body System / Region Q Cranial Cavity and Brain |
Approach 0 Open |
Substance A Stem Cells, Embryonic |
Qualifier Z No Qualifier |
| Body System / Region Q Cranial Cavity and Brain |
Approach 0 Open |
Substance E Stem Cells, Somatic |
Qualifier 0 Autologous 1 Nonautologous |
| Body System / Region Q Cranial Cavity and Brain |
Approach 3 Percutaneous |
Substance 0 Antineoplastic |
Qualifier 4 Liquid Brachytherapy Radioisotope 5 Other Antineoplastic M Monoclonal Antibody |
| Body System / Region Q Cranial Cavity and Brain |
Approach 3 Percutaneous |
Substance 2 Anti-infective |
Qualifier 8 Oxazolidinones 9 Other Anti-infective |
| Body System / Region Q Cranial Cavity and Brain |
Approach 3 Percutaneous |
Substance 3 Anti-inflammatory 6 Nutritional Substance 7 Electrolytic and Water Balance Substance A Stem Cells, Embryonic B Local Anesthetic H Radioactive Substance K Other Diagnostic Substance N Analgesics, Hypnotics, Sedatives T Destructive Agent |
Qualifier Z No Qualifier |
| Body System / Region Q Cranial Cavity and Brain |
Approach 3 Percutaneous |
Substance E Stem Cells, Somatic |
Qualifier 0 Autologous 1 Nonautologous |
| Body System / Region Q Cranial Cavity and Brain |
Approach 3 Percutaneous |
Substance G Other Therapeutic Substance |
Qualifier C Other Substance |
| Body System / Region Q Cranial Cavity and Brain |
Approach 3 Percutaneous |
Substance S Gas |
Qualifier F Other Gas |
| Body System / Region Q Cranial Cavity and Brain |
Approach 7 Via Natural or Artificial Opening |
Substance 0 Antineoplastic |
Qualifier 4 Liquid Brachytherapy Radioisotope 5 Other Antineoplastic M Monoclonal Antibody |
| Body System / Region Q Cranial Cavity and Brain |
Approach 7 Via Natural or Artificial Opening |
Substance S Gas |
Qualifier F Other Gas |
| Body System / Region R Spinal Canal |
Approach 0 Open |
Substance A Stem Cells, Embryonic |
Qualifier Z No Qualifier |
| Body System / Region R Spinal Canal |
Approach 0 Open |
Substance E Stem Cells, Somatic |
Qualifier 0 Autologous 1 Nonautologous |
| Body System / Region R Spinal Canal |
Approach 3 Percutaneous |
Substance 0 Antineoplastic |
Qualifier 2 High-dose Interleukin-2 3 Low-dose Interleukin-2 4 Liquid Brachytherapy Radioisotope 5 Other Antineoplastic M Monoclonal Antibody |
| Body System / Region R Spinal Canal |
Approach 3 Percutaneous |
Substance 2 Anti-infective |
Qualifier 8 Oxazolidinones 9 Other Anti-infective |
| Body System / Region R Spinal Canal |
Approach 3 Percutaneous |
Substance 3 Anti-inflammatory 6 Nutritional Substance 7 Electrolytic and Water Balance Substance A Stem Cells, Embryonic B Local Anesthetic C Regional Anesthetic H Radioactive Substance K Other Diagnostic Substance N Analgesics, Hypnotics, Sedatives T Destructive Agent |
Qualifier Z No Qualifier |
| Body System / Region R Spinal Canal |
Approach 3 Percutaneous |
Substance E Stem Cells, Somatic |
Qualifier 0 Autologous 1 Nonautologous |
| Body System / Region R Spinal Canal |
Approach 3 Percutaneous |
Substance G Other Therapeutic Substance |
Qualifier C Other Substance |
| Body System / Region R Spinal Canal |
Approach 3 Percutaneous |
Substance S Gas |
Qualifier F Other Gas |
| Body System / Region R Spinal Canal |
Approach 7 Via Natural or Artificial Opening |
Substance S Gas |
Qualifier F Other Gas |
| Body System / Region S Epidural Space |
Approach 3 Percutaneous |
Substance 0 Antineoplastic |
Qualifier 2 High-dose Interleukin-2 3 Low-dose Interleukin-2 4 Liquid Brachytherapy Radioisotope 5 Other Antineoplastic M Monoclonal Antibody |
| Body System / Region S Epidural Space |
Approach 3 Percutaneous |
Substance 2 Anti-infective |
Qualifier 8 Oxazolidinones 9 Other Anti-infective |
| Body System / Region S Epidural Space |
Approach 3 Percutaneous |
Substance 3 Anti-inflammatory 6 Nutritional Substance 7 Electrolytic and Water Balance Substance B Local Anesthetic C Regional Anesthetic H Radioactive Substance K Other Diagnostic Substance N Analgesics, Hypnotics, Sedatives T Destructive Agent |
Qualifier Z No Qualifier |
| Body System / Region S Epidural Space |
Approach 3 Percutaneous |
Substance G Other Therapeutic Substance |
Qualifier C Other Substance |
| Body System / Region S Epidural Space |
Approach 3 Percutaneous |
Substance S Gas |
Qualifier F Other Gas |
| Body System / Region S Epidural Space |
Approach 7 Via Natural or Artificial Opening |
Substance S Gas |
Qualifier F Other Gas |
| Body System / Region T Peripheral Nerves and Plexi X Cranial Nerves |
Approach 3 Percutaneous |
Substance 3 Anti-inflammatory B Local Anesthetic C Regional Anesthetic T Destructive Agent |
Qualifier Z No Qualifier |
| Body System / Region T Peripheral Nerves and Plexi X Cranial Nerves |
Approach 3 Percutaneous |
Substance G Other Therapeutic Substance |
Qualifier C Other Substance |
| Body System / Region U Joints |
Approach 0 Open |
Substance 2 Anti-infective |
Qualifier 8 Oxazolidinones 9 Other Anti-infective |
| Body System / Region U Joints |
Approach 0 Open |
Substance G Other Therapeutic Substance |
Qualifier B Recombinant Bone Morphogenetic Protein |
| Body System / Region U Joints |
Approach 3 Percutaneous |
Substance 0 Antineoplastic |
Qualifier 4 Liquid Brachytherapy Radioisotope 5 Other Antineoplastic M Monoclonal Antibody |
| Body System / Region U Joints |
Approach 3 Percutaneous |
Substance 2 Anti-infective |
Qualifier 8 Oxazolidinones 9 Other Anti-infective |
| Body System / Region U Joints |
Approach 3 Percutaneous |
Substance 3 Anti-inflammatory 6 Nutritional Substance 7 Electrolytic and Water Balance Substance B Local Anesthetic H Radioactive Substance K Other Diagnostic Substance N Analgesics, Hypnotics, Sedatives T Destructive Agent |
Qualifier Z No Qualifier |
| Body System / Region U Joints |
Approach 3 Percutaneous |
Substance G Other Therapeutic Substance |
Qualifier B Recombinant Bone Morphogenetic Protein C Other Substance |
| Body System / Region U Joints |
Approach 3 Percutaneous |
Substance S Gas |
Qualifier F Other Gas |
| Body System / Region V Bones |
Approach 0 Open |
Substance G Other Therapeutic Substance |
Qualifier B Recombinant Bone Morphogenetic Protein |
| Body System / Region V Bones |
Approach 3 Percutaneous |
Substance 0 Antineoplastic |
Qualifier 5 Other Antineoplastic M Monoclonal Antibody |
| Body System / Region V Bones |
Approach 3 Percutaneous |
Substance 2 Anti-infective |
Qualifier 8 Oxazolidinones 9 Other Anti-infective |
| Body System / Region V Bones |
Approach 3 Percutaneous |
Substance 3 Anti-inflammatory 6 Nutritional Substance 7 Electrolytic and Water Balance Substance B Local Anesthetic H Radioactive Substance K Other Diagnostic Substance N Analgesics, Hypnotics, Sedatives T Destructive Agent |
Qualifier Z No Qualifier |
| Body System / Region V Bones |
Approach 3 Percutaneous |
Substance G Other Therapeutic Substance |
Qualifier B Recombinant Bone Morphogenetic Protein C Other Substance |
| Body System / Region W Lymphatics |
Approach 3 Percutaneous |
Substance 0 Antineoplastic |
Qualifier 5 Other Antineoplastic M Monoclonal Antibody |
| Body System / Region W Lymphatics |
Approach 3 Percutaneous |
Substance 2 Anti-infective |
Qualifier 8 Oxazolidinones 9 Other Anti-infective |
| Body System / Region W Lymphatics |
Approach 3 Percutaneous |
Substance 3 Anti-inflammatory 6 Nutritional Substance 7 Electrolytic and Water Balance Substance B Local Anesthetic H Radioactive Substance K Other Diagnostic Substance N Analgesics, Hypnotics, Sedatives T Destructive Agent |
Qualifier Z No Qualifier |
| Body System / Region W Lymphatics |
Approach 3 Percutaneous |
Substance G Other Therapeutic Substance |
Qualifier C Other Substance |
| Body System / Region Y Pericardial Cavity |
Approach 3 Percutaneous |
Substance 0 Antineoplastic |
Qualifier 4 Liquid Brachytherapy Radioisotope 5 Other Antineoplastic M Monoclonal Antibody |
| Body System / Region Y Pericardial Cavity |
Approach 3 Percutaneous |
Substance 2 Anti-infective |
Qualifier 8 Oxazolidinones 9 Other Anti-infective |
| Body System / Region Y Pericardial Cavity |
Approach 3 Percutaneous |
Substance 3 Anti-inflammatory 6 Nutritional Substance 7 Electrolytic and Water Balance Substance B Local Anesthetic H Radioactive Substance K Other Diagnostic Substance N Analgesics, Hypnotics, Sedatives T Destructive Agent |
Qualifier Z No Qualifier |
| Body System / Region Y Pericardial Cavity |
Approach 3 Percutaneous |
Substance G Other Therapeutic Substance |
Qualifier C Other Substance |
| Body System / Region Y Pericardial Cavity |
Approach 3 Percutaneous |
Substance S Gas |
Qualifier F Other Gas |
| Body System / Region Y Pericardial Cavity |
Approach 7 Via Natural or Artificial Opening |
Substance 0 Antineoplastic |
Qualifier 4 Liquid Brachytherapy Radioisotope 5 Other Antineoplastic M Monoclonal Antibody |
| Body System / Region Y Pericardial Cavity |
Approach 7 Via Natural or Artificial Opening |
Substance S Gas |
Qualifier F Other Gas |